xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

428

KUANetal.

treatment options. World Neurosurg . 2019;126:194-211. https:// doi.org/10.1016/j.wneu.2019.03.014 1368. Yuan Y, Ye J, Qiu H, et al. Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experi ence in China. J Cancer . 2018;9(1):174-181. https://doi.org/10. 7150/jca.21605 1369. Tsutsumi K, Ahmed KH, Goshtasbi K, et al. Impact of esthesioneuroblastoma treatment delays on overall patient survival. Laryngoscope . 2023;133(4):764-772. https://doi.org/ 10.1002/lary.30136 1370. Kiyofuji S, Agarwal V, Hughes JD, et al. Delaying postoper ative radiotherapy in low-grade esthesioneuroblastoma: is it worth the wait? J Neurol Surg B Skull Base . 2021;82(Suppl. 3):e166-e171. https://doi.org/10.1055/s-0040-1708854 1371. Cranmer LD, Chau B, Rockhill JK, Ferreira M, Liao JJ. Chemotherapy in esthesioneuroblastoma/olfactory neu roblastoma: an analysis of the surveillance epidemiology and end results (SEER) 1973-2015 database. Am J Clin Oncol . 2020;43(3):203-209. https://doi.org/10.1097/COC. 0000000000000649 1372. Brisson RJ, Quinn TJ, Deraniyagala RL. The role of chemotherapy in the management of olfactory neu roblastoma: a 40-year surveillance, epidemiology, and end results registry study. Health Sci Rep . 2021;4(2):e257. https://doi.org/10.1002/hsr2.257 1373. Venkatramani R, Pan H, Furman WL, et al. Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer . 2016;63(3):465-470. https://doi.org/10.1002/pbc.25817 1374. Romani C, Bignotti E, Mattavelli D, et al. Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets. Cancers . 2021;13(11):2527. https://doi.org/10.3390/cancers13112527 1375. Cracolici V, Wang EW, Gardner PA, et al. SSTR2 expression in olfactory neuroblastoma: clinical and therapeutic implica tions. Head Neck Pathol . 2021;15(4):1185-1191. https://doi.org/ 10.1007/s12105-021-01329-1 1376. Meerwein CM, Nikolaou G, Binz GHA, Soyka MB, Holzmann D. Surgery as single-modality treatment for early-stage olfac tory neuroblastoma: an institutional experience, systematic review and meta-analysis. Am J Rhinol Allergy . 2021;35(4):525 534. https://doi.org/10.1177/1945892420973163 1377. Vuong HG, Ngo TNM, Dunn IF. Consolidating the Hyams grading system in esthesioneuroblastoma – an individual par ticipant data meta-analysis. J Neurooncol . 2021;153(1):15-22. https://doi.org/10.1007/s11060-021-03746-2 1378. Woods R, Subramaniam T, Leader M, McConn-Walsh R, O’Neill J, Lacy P. Changing trends in the management of esthesioneuroblastoma: Irish and international perspectives. J Neurol Surg B . 2018;79(03):262-268. https://doi.org/10.1055/s 0037-1607298 1379. Arnold MA, Farnoosh S, Gore MR. Comparing Kadish and modified Dulguerov staging systems for olfactory neuroblas toma: an individual participant data meta-analysis. Otolaryn gol Head Neck Surg . 2020;163(3):418-427. https://doi.org/10. 1177/0194599820915487 1380. Liu L, Zhong Q, Zhao T, Chen D, Xu Y, Li G. Model to predict cause-specific mortality in patients with olfactory neuroblas toma: a competing risk analysis. Radiat Oncol . 2021;16(1):103. https://doi.org/10.1186/s13014-021-01784-8

1353. De Virgilio A, Costantino A, Sebastiani D, et al. Elective neck irradiation in the management of esthesioneuroblas toma: a systematic review and meta-analysis. Rhinology . 2021;59(5):433-440. https://doi.org/10.4193/Rhin21.139 1354. Kuan EC, Nasser HB, Carey RM, et al. A population-based analysis of nodal metastases in esthesioneuroblastomas of the sinonasal tract. Laryngoscope . 2019;129(5):1025-1029. https:// doi.org/10.1002/lary.27301 1355. Wu K, Avila SA, Bhuyan R, et al. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature. Orbit . 2022;41(1):1-14. https://doi.org/10.1080/ 01676830.2020.1852262 1356. Herr MW, Gray ST, Erman AB, Curry WT, Deschler DG, Lin DT. Orbital preservation in patients with esthesioneuroblas toma. J Neurol Surg B Skull Base . 2013;74(3):142-145. https:// doi.org/10.1055/s-0033-1338259 1357. Su SY, Bell D, Ferrarotto R, et al. Outcomes for olfactory neu roblastoma treated with induction chemotherapy. HeadNeck . 2017;39(8):1671-1679. https://doi.org/10.1002/hed.24822 1358. Miller KC, Marinelli JP, Janus JR, et al. Induction ther apy prior to surgical resection for patients presenting with locally advanced esthesioneuroblastoma. J Neurol Surg B Skull Base . 2021;82(Suppl. 3):e131-e137. https://doi.org/10.1055/s 0039-3402026 1359. Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol Head Neck Surg . 2014;140(10):951-955. https://doi. org/10.1001/jamaoto.2014.1675 1360. Nakagawa T, Kodama S, Kobayashi M, et al. Endoscopic endonasal management of esthesioneuroblastoma: a retrospective multicenter study. Auris Nasus Larynx . 2018;45(2):281-285. https://doi.org/10.1016/j.anl.2017.05.001 1361. Tajudeen BA, Adappa ND, Kuan EC, et al. Smell preservation following endoscopic unilateral resection of esthesioneurob lastoma: a multi-institutional experience. Int Forum Allergy Rhinol . 2016;6(10):1047-1050. https://doi.org/10.1002/alr.21794 1362. Gompel JJV, Janus JR, Hughes JD, et al. Esthesioneuroblas toma and olfactory preservation: is it reasonable to attempt smell preservation? J Neurol Surg B Skull Base . 2018;79(2):184 188. https://doi.org/10.1055/s-0037-1606307 1363. Gomez Galarce M, Yanez-Siller JC, Carrau RL, et al. Endonasal anatomy of the olfactory neural network: surgi cal implications. Laryngoscope . 2018;128(11):2473-2477. https:// doi.org/10.1002/lary.27194 1364. Duo GS, Feng JL, Zhang ZY, Wang LJ. Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database. Can cer/Radiothérapie . 2022;26(5):663-669. https://doi.org/10.1016/ j.canrad.2021.12.006 1365. Orton A, Boothe D, Evans D, et al. Esthesioneuroblastoma: a patterns-of-care and outcomes analysis of the national cancer database. Neurosurgery . 2018;83(5):940-947. https://doi.org/10. 1093/neuros/nyx535 1366. Xiong L, Zeng XL, Guo CK, Liu AW, Huang L. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients. BMC Cancer . 2017;17(1):254. https://doi.org/10.1186/s12885-017-3247-z 1367. Fiani B, Quadri SA, Cathel A, et al. Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current